eli lilly retatrutide trials Today, we shared new data from two Phase 3 of retatrutide, our investigational triple agonist. Learn more at our link in bio Retatrutide Shows 28% Weight Loss

What comes included with this product

Atherogenic oxidized LDL is thus thought to be essential in the production of atherosclerosis plaque

The combination supports a more consistent and synergistic elevation of GH, leading to downstream increases in insulin-like growth factor 1 (IGF-1)

GLP-1 therapies reduce the risk of stroke , heart attack , and kidney damage , improving long-term survival

Novo sells it under three brand names: Ozempic (an injection, for type 2 diabetes), Wegovy (the same molecule at higher doses, for obesity), and Rybelsus (an oral tablet)

This reflects a key limitation: GLP-1 medications can reduce appetite and support weight loss, but they do not by themselves establish a long-term metabolic framework for maintaining that loss